Trial Profile

Efficacy, tolerability and quality-of-life effects of paclitaxel versus paclitaxel + topotecan vs paclitaxel + carboplatin in patients with resistant ovarian cancer who have failed first- or second-line platinum and taxane treatment

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 11 Jul 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

03 Jul 2019 Results from a nomogram model developed to improve prediction of overall survival in patients treated with chemotherapy in the AURELIA and CARTAXHY studies published in the European Journal of Cancer.
11 May 2011 Results published in the Annals of Oncology.
05 Nov 2010 New trial record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com